18-59431112-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_133459.4(CCBE1):c.*4796G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.817 in 152,192 control chromosomes in the GnomAD database, including 50,948 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.82 ( 50947 hom., cov: 32)
Exomes 𝑓: 1.0 ( 1 hom. )
Consequence
CCBE1
NM_133459.4 3_prime_UTR
NM_133459.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.30
Genes affected
CCBE1 (HGNC:29426): (collagen and calcium binding EGF domains 1) This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 18-59431112-C-T is Benign according to our data. Variant chr18-59431112-C-T is described in ClinVar as [Benign]. Clinvar id is 327588.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.873 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCBE1 | NM_133459.4 | c.*4796G>A | 3_prime_UTR_variant | 11/11 | ENST00000439986.9 | NP_597716.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCBE1 | ENST00000439986 | c.*4796G>A | 3_prime_UTR_variant | 11/11 | 1 | NM_133459.4 | ENSP00000404464.2 | |||
CCBE1 | ENST00000649564 | c.*4796G>A | 3_prime_UTR_variant | 12/12 | ENSP00000497183.1 | |||||
CCBE1 | ENST00000650467.2 | c.*4796G>A | 3_prime_UTR_variant | 9/9 | ENSP00000496897.2 |
Frequencies
GnomAD3 genomes AF: 0.818 AC: 124330AN: 152072Hom.: 50928 Cov.: 32
GnomAD3 genomes
AF:
AC:
124330
AN:
152072
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 1.00 AC: 2AN: 2Hom.: 1 Cov.: 0 AF XY: 1.00 AC XY: 2AN XY: 2
GnomAD4 exome
AF:
AC:
2
AN:
2
Hom.:
Cov.:
0
AF XY:
AC XY:
2
AN XY:
2
Gnomad4 NFE exome
AF:
GnomAD4 genome AF: 0.817 AC: 124396AN: 152190Hom.: 50947 Cov.: 32 AF XY: 0.813 AC XY: 60522AN XY: 74404
GnomAD4 genome
AF:
AC:
124396
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
60522
AN XY:
74404
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2801
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hennekam lymphangiectasia-lymphedema syndrome 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at